Allstate Corporation’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$695K Buy
+10,574
New +$552K 0.01% 924
2025
Q1
Sell
-3,245
Closed -$225K 592
2024
Q4
$225K Buy
+3,245
New +$312K 0.01% 616
2023
Q1
Sell
-7,496
Closed -$766K 258
2022
Q4
$766K Buy
7,496
+263
+4% +$26.1K 0.02% 411
2022
Q3
$653K Buy
+7,233
New +$794K 0.02% 435
2022
Q1
Sell
-15,587
Closed -$2.62M 615
2021
Q4
$2.62M Buy
+15,587
New +$2.54M 0.05% 325
2020
Q2
Sell
-10,537
Closed -$773K 676
2020
Q1
$773K Sell
10,537
-13,105
-55% -$1.3M 0.03% 260
2019
Q4
$2.91M Buy
23,642
+700
+3% +$86.2K 0.05% 222
2019
Q3
$2.81M Sell
22,942
-455
-2% -$51.3K 0.05% 219
2019
Q2
$2.52M Buy
23,397
+7
+0% +$725 0.05% 242
2019
Q1
$2.31M Buy
23,390
+480
+2% +$47.2K 0.06% 230
2018
Q4
$2.06M Buy
+22,910
New +$2.25M 0.07% 218

Other funds holding CE

Allstate Corporation's CE Position: Q1 2026 in Review

Allstate Corporation opened a new position in Celanese (CE) in Q1 2026: 10,574 shares worth $695K. The stake represents 0.01% of the portfolio and ranks #924 among its holdings. This is a return to the name: Allstate Corporation previously reported a position in CE as recently as Q4 2024.

Allstate Corporation first reported a position in CE in Q4 2018 and has held it in 11 quarters since. The position peaked at $2.91M in Q4 2019. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • Allstate Corporation held 10,574 shares of Celanese worth $695K as of Q1 2026.
  • Celanese was a new Allstate Corporation position in Q1 2026.
  • Celanese made up 0.01% of Allstate Corporation's portfolio in Q1 2026, its #924 holding.
  • Allstate Corporation first reported a position in Celanese in Q4 2018 and has held it in 11 quarters since.
  • Allstate Corporation's Celanese position peaked at $2.91M in Q4 2019.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on Allstate Corporation's 13F filing for Q1 2026, filed 11 May 2026.